Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

ASG-5ME evaluated in patients with pancreatic ductal adenocarcinoma

Jan. 28, 2013

BioInvent reports first results from phase I human antibody candidate study in multiple myeloma

Jan. 24, 2013

Innate Pharma presents phase I results for their anti-KIR antibody in AML

Jan. 18, 2013

Paladin Labs enters into agreement for novel neuroblastoma drug

Jan. 17, 2013

French researchers design novel immunocytokines

Jan. 17, 2013

Patrys progresses phase I/IIa PAT-SM6 trial to second patient group

Jan. 15, 2013

Morphotek discloses results from phase III study in platinum-sensitive epithelial ovarian cancer

Jan. 14, 2013

Merus selects lead candidate for AML

Jan. 9, 2013

First-in-human phase Ib study of ARGX-110 begins

Jan. 8, 2013

OncoTherapy patents novel potential cancer vaccines

Jan. 8, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 12, 2025.
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026